MetLife Investment Management’s Lydall, Inc. LDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-6,860
Closed -$426K 2621
2021
Q3
$426K Hold
6,860
﹤0.01% 1615
2021
Q2
$415K Hold
6,860
﹤0.01% 1683
2021
Q1
$231K Sell
6,860
-1,534
-18% -$52.5K ﹤0.01% 1975
2020
Q4
$252K Hold
8,394
﹤0.01% 1850
2020
Q3
$139K Hold
8,394
﹤0.01% 2069
2020
Q2
$114K Buy
+8,394
New +$92.9K ﹤0.01% 2196
2020
Q1
Sell
-8,342
Closed -$171K 2328
2019
Q4
$171K Hold
8,342
﹤0.01% 2063
2019
Q3
$208K Hold
8,342
﹤0.01% 1924
2019
Q2
$169K Hold
8,342
﹤0.01% 2135
2019
Q1
$196K Hold
8,342
﹤0.01% 1995
2018
Q4
$169K Hold
8,342
﹤0.01% 1995
2018
Q3
$360K Hold
8,342
﹤0.01% 1743
2018
Q2
$364K Hold
8,342
﹤0.01% 1608
2018
Q1
$403K Hold
8,342
﹤0.01% 1499
2017
Q4
$423K Buy
+8,342
New +$457K ﹤0.01% 1495

MetLife Investment Management's LDL Position: Q4 2021 in Review

MetLife Investment Management sold out of Lydall, Inc. (LDL) in Q4 2021, closing a stake of 6,860 shares — an estimated $426K sold.

MetLife Investment Management first reported a position in LDL in Q4 2017 and held it in 15 quarters. The position peaked at $426K in Q3 2021. 1 fund tracked by Wall St. Rank holds LDL as of Q4 2021.

  • MetLife Investment Management reported no remaining Lydall, Inc. position as of Q4 2021 after selling out during the quarter.
  • MetLife Investment Management sold 6,860 Lydall, Inc. shares in Q4 2021, an estimated $426K.
  • MetLife Investment Management first reported a position in Lydall, Inc. in Q4 2017 and held it in 15 quarters.
  • MetLife Investment Management's Lydall, Inc. position peaked at $426K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Lydall, Inc. as of Q4 2021.

Based on MetLife Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.